AssetMark Inc’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288 Buy
+34
New +$226 ﹤0.01% 3377
2025
Q1
Sell
-10
Closed -$91 2759
2024
Q4
$91 Buy
+10
New +$97 ﹤0.01% 2536
2024
Q1
Sell
-7
Closed -$151 2111
2023
Q4
$151 Buy
7
+5
+250% +$92 ﹤0.01% 1795
2023
Q3
$37 Buy
+2
New +$47 ﹤0.01% 1726
2022
Q2
Sell
-3
Closed 1660
2022
Q1
$0 Sell
3
-17
-85% -$1.23K ﹤0.01% 1739
2021
Q4
$2K Buy
+20
New +$2.39K ﹤0.01% 1390
2021
Q1
Sell
-45
Closed -$9K 1526
2020
Q4
$9K Buy
+45
New +$9.15K ﹤0.01% 948
2019
Q3
Sell
-14
Closed -$1K 1418
2019
Q2
$1K Buy
14
+2
+17% +$117 ﹤0.01% 1274
2019
Q1
$1K Hold
12
﹤0.01% 1280
2018
Q4
$1K Buy
+12
New +$734 ﹤0.01% 1359

Other funds holding TDOC

AssetMark Inc's TDOC Position: Q2 2026 in Review

AssetMark Inc opened a new position in Teladoc Health (TDOC) in Q2 2026: 34 shares worth $288. The stake represents ﹤0.01% of the portfolio and ranks #3377 among its holdings. This is a return to the name: AssetMark Inc previously reported a position in TDOC as recently as Q4 2024.

AssetMark Inc first reported a position in TDOC in Q4 2018 and has held it in 10 quarters since. The position peaked at $9K in Q4 2020. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • AssetMark Inc held 34 shares of Teladoc Health worth $288 as of Q2 2026.
  • Teladoc Health was a new AssetMark Inc position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3377 holding.
  • AssetMark Inc first reported a position in Teladoc Health in Q4 2018 and has held it in 10 quarters since.
  • AssetMark Inc's Teladoc Health position peaked at $9K in Q4 2020.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.